85 related articles for article (PubMed ID: 23900643)
1. CD176 antiserum treatment leads to a therapeutic response in a murine model of leukemia.
Yi B; Zhang Z; Zhang M; Schwartz-Albiez R; Cao Y
Oncol Rep; 2013 Oct; 30(4):1841-7. PubMed ID: 23900643
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of the apoptosis induced by CD176 antibody in human leukemic cells.
Yi B; Zhang M; Schwartz-Albiez R; Cao Y
Int J Oncol; 2011 Jun; 38(6):1565-73. PubMed ID: 21455576
[TBL] [Abstract][Full Text] [Related]
3. CD176 single-chain variable antibody fragment inhibits the adhesion of cancer cells to endothelial cells and hepatocytes.
Liu J; Yi B; Zhang Z; Cao Y
Front Med; 2016 Jun; 10(2):204-11. PubMed ID: 27090911
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD175 (Tn), CD175s (sialosyl-Tn) and CD176 (Thomsen-Friedenreich antigen) on malignant human hematopoietic cells.
Cao Y; Merling A; Karsten U; Goletz S; Punzel M; Kraft R; Butschak G; Schwartz-Albiez R
Int J Cancer; 2008 Jul; 123(1):89-99. PubMed ID: 18398838
[TBL] [Abstract][Full Text] [Related]
5. CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors.
Dragon AC; Beermann LM; Umland M; Bonifacius A; Malinconico C; Ruhl L; Kehler P; Gellert J; Weiß L; Mayer-Hain S; Zimmermann K; Riese S; Thol F; Beutel G; Maecker-Kolhoff B; Yamamoto F; Blasczyk R; Schambach A; Hust M; Hudecek M; Eiz-Vesper B
Front Immunol; 2023; 14():1219165. PubMed ID: 37915564
[TBL] [Abstract][Full Text] [Related]
6. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells.
Lin WM; Karsten U; Goletz S; Cheng RC; Cao Y
Int J Exp Pathol; 2011 Apr; 92(2):97-105. PubMed ID: 21070402
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune response induced by dendritic cells exerts anti-tumor effect in murine model of leukemia.
Tsai BY; Lin YL; Chiang BL
J Autoimmun; 2010 Jun; 34(4):364-70. PubMed ID: 19818583
[TBL] [Abstract][Full Text] [Related]
9. A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates.
Lo-Man R; Vichier-Guerre S; Perraut R; Dériaud E; Huteau V; BenMohamed L; Diop OM; Livingston PO; Bay S; Leclerc C
Cancer Res; 2004 Jul; 64(14):4987-94. PubMed ID: 15256473
[TBL] [Abstract][Full Text] [Related]
10. Cluster binding studies with two anti-Thomsen-Friedenreich (anti-core-1, CD176, TF) antibodies: Evidence for a multiple TF epitope.
Flechner A; Butschak G; Löffler A; Rühmann J; Nishimura SI; Dölling R; Purfürst B; Goletz S; Danielczyk A; Karsten U
Int Immunopharmacol; 2019 Jul; 72():186-194. PubMed ID: 30999209
[TBL] [Abstract][Full Text] [Related]
11. Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6.
Ulsemer P; Henderson G; Toutounian K; Löffler A; Schmidt J; Karsten U; Blaut M; Goletz S
Cancer Immunol Immunother; 2013 May; 62(5):875-87. PubMed ID: 23381581
[TBL] [Abstract][Full Text] [Related]
12. Expression of MUC1 and CD176 (Thomsen-Friedenreich antigen) in papillary thyroid carcinomas.
Zhan XX; Zhao B; Diao C; Cao Y; Cheng RC
Endocr Pathol; 2015 Mar; 26(1):21-6. PubMed ID: 25614211
[TBL] [Abstract][Full Text] [Related]
13. Naked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in mice.
Lladser A; Párraga M; Quevedo L; Carmen Molina M; Silva S; Ferreira A; Billetta R; G Quest AF
Immunobiology; 2006; 211(1-2):11-27. PubMed ID: 16446167
[TBL] [Abstract][Full Text] [Related]
14. Detection and characterisation of disseminated tumour cells in bone marrow of breast cancer patients by immunostaining of Her-2 and MUC-1 in combination with Thomsen-Friedenreich (CD176).
Andergassen U; Kölbl AC; Zebisch M; Heublein S; Hutter S; Ilmer M; Schindlbeck C; Friese K; Jeschke U
Histol Histopathol; 2014 Jul; 29(7):913-23. PubMed ID: 24399516
[TBL] [Abstract][Full Text] [Related]
15. Tk, a new colon tumor-associated antigen resulting from altered O-glycosylation.
Meichenin M; Rocher J; Galanina O; Bovin N; Nifantev N; Sherman A; Cassagnau E; Heymann MF; Bara J; Fraser RH; Le Pendu J
Cancer Res; 2000 Oct; 60(19):5499-507. PubMed ID: 11034094
[TBL] [Abstract][Full Text] [Related]
16. [Gangliosides as carbohydrate antigens associated with cancer and their possible use in tumor immunotherapy].
Horwacik I
Przegl Lek; 2004; 61 Suppl 2():14-9. PubMed ID: 15686040
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice.
Ling X; Wang Y; Dietrich MF; Andreeff M; Arlinghaus RB
Oncogene; 2006 Jul; 25(32):4483-90. PubMed ID: 16547503
[TBL] [Abstract][Full Text] [Related]
18. Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy.
Rountree RB; Mandl SJ; Nachtwey JM; Dalpozzo K; Do L; Lombardo JR; Schoonmaker PL; Brinkmann K; Dirmeier U; Laus R; Delcayre A
Cancer Res; 2011 Aug; 71(15):5235-44. PubMed ID: 21670078
[TBL] [Abstract][Full Text] [Related]
19. The effects of passive immunization with tumor-specific antiserum on the active immune response of mice to sublines of leukemia L1210.
Carlson GA; Terres G
J Immunol; 1978 Nov; 121(5):1752-9. PubMed ID: 712064
[TBL] [Abstract][Full Text] [Related]
20. CIGB-247: a VEGF-based therapeutic vaccine that reduces experimental and spontaneous lung metastasis of C57Bl/6 and BALB/c mouse tumors.
Bequet-Romero M; Morera Y; Ayala-Ávila M; Ancizar J; Soria Y; Blanco A; Suárez-Alba J; Gavilondo JV
Vaccine; 2012 Feb; 30(10):1790-9. PubMed ID: 22240345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
